ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $235,000 | -11.3% | 17,247 | +8.6% | 0.27% | +34.0% |
| Q3 2018 | $265,000 | -29.5% | 15,886 | -33.2% | 0.20% | -33.2% |
| Q2 2018 | $376,000 | -0.5% | 23,796 | -20.1% | 0.30% | -25.5% |
| Q1 2018 | $378,000 | +116.0% | 29,779 | +94.7% | 0.41% | +73.6% |
| Q2 2017 | $175,000 | -61.5% | 15,296 | -29.9% | 0.24% | -57.5% |
| Q1 2017 | $454,000 | -65.7% | 21,805 | -65.7% | 0.55% | -68.4% |
| Q4 2016 | $1,322,000 | -3.9% | 63,571 | +51.5% | 1.75% | -14.0% |
| Q3 2016 | $1,375,000 | -26.6% | 41,960 | -44.1% | 2.04% | -33.5% |
| Q2 2016 | $1,873,000 | +9.7% | 75,002 | +7.5% | 3.06% | +10.1% |
| Q1 2016 | $1,708,000 | +40.7% | 69,742 | +89.7% | 2.78% | +39.7% |
| Q4 2015 | $1,214,000 | +61.7% | 36,756 | +60.3% | 1.99% | +75.4% |
| Q3 2015 | $751,000 | -21.9% | 22,925 | +26.4% | 1.14% | -16.0% |
| Q2 2015 | $961,000 | +344.9% | 18,133 | +144.3% | 1.35% | +1435.2% |
| Q4 2014 | $216,000 | -28.0% | 7,422 | -68.6% | 0.09% | -20.0% |
| Q3 2014 | $300,000 | -46.4% | 23,660 | -15.2% | 0.11% | -1.8% |
| Q2 2014 | $560,000 | – | 27,893 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |